Clinical Commander

Back to dossier
cardio.cardiac-tamponade.post-procedural.v1PRODUCTION
cardio.cardiac-tamponade.post-procedural.v1

Cardiac tamponade — post-procedural / hemopericardium / iatrogenic

cardiologyacuteadult
Hard-required inputs
0 / 9
Care setting:

Encounter flow

9/12 authored

Canonical 12-phase frame with authored status for this dossier.

Current phase

Frame

Detailed

Post-procedural / iatrogenic tamponade — emergent pericardiocentesis + simultaneous cardiothoracic surgery activation + anticoagulation reversal (ESC 2015 §Iatrogenic Tamponade)

Inputs
1
Actions
0
Advance rule
Set
Advance when

iatrogenic-context tamponade physiology suspected

Patient inputs (9)

Older patients have higher complication risk + worse outcomes (Holmes JACC 2011)

Compensatory tachycardia in tamponade physiology (ESC 2015)

PCI vs ablation vs lead vs surgery vs trauma — drives surgical approach + reversal strategy (ESC 2015 §Iatrogenic)

UFH, DOAC, warfarin, DAPT — drives reversal strategy (Bhatt Circulation 2018; Pollack NEJM 2017; Connolly NEJM 2019)

Definitive bedside dx — chamber collapse, IVC, swinging heart; SMALL effusion can cause tamponade if rapid accumulation (ESC 2015 Class I; Spodick Circulation 2003)

Coagulopathy quantification for warfarin reversal (Bhatt 2018)

Hemorrhagic loss quantification + transfusion threshold (ESC 2015)

Procedural bleeding risk + transfusion threshold; DAPT effect on platelet function (Bhatt 2018)

Hypotension is part of Beck triad; rapid accumulation produces tamponade at small volumes (Spodick Circulation 2003)

* = hard-required. Engine cannot meaningfully run until these are filled.

Severity triggers (5)

5 need judgement
  • informationallife_threateningrefractory_pericardial_bleeding_requiring_emergent_surgery
    Persistent pericardial bleeding (>200 mL/h drainage output OR ongoing transfusion requirement) despite reversal + drainage — surgical exploration mandatory (ESC 2015 §Iatrogenic; Holmes JACC 2011)
    Trigger could not be auto-evaluated — needs clinician judgement.
  • informationallife_threateninganticoagulant_associated_pericardial_bleeding_with_hemodynamic_compromise
    Active warfarin/DOAC/UFH at time of perforation with hemodynamic compromise — emergent reversal mandatory (Bhatt Circulation 2018; Pollack NEJM 2017; Connolly NEJM 2019)
    Trigger could not be auto-evaluated — needs clinician judgement.
  • informationallife_threateningpost_cardiotomy_tamponade_with_clot_loculation
    Tamponade in first 7d post-cardiac-surgery with loculated clot on echo — needle pericardiocentesis often inadequate (ESC 2015 §Post-Cardiotomy)
    Trigger could not be auto-evaluated — needs clinician judgement.
  • informationallife_threateningtraumatic_hemopericardium_with_aortic_or_great_vessel_injury
    Penetrating chest trauma to cardiac box with tamponade + suspected aortic/great vessel injury (ATLS; ESC 2015 §Trauma)
    Trigger could not be auto-evaluated — needs clinician judgement.
  • informationalseverepost_lead_perforation_requiring_repositioning
    Pacer/ICD lead perforation through RV/RA wall causing tamponade hours-to-days post-implant (Cano AJC 2010)
    Trigger could not be auto-evaluated — needs clinician judgement.

Workflow calculators

Run this disease's risk and dosing calculators inline.

RED_FLAGSrequiredDrives risk stratification
Loading…

Recommended regimen

Iatrogenic tamponade — emergent drainage + anticoagulation reversal + surgical readiness (ESC 2015 §Iatrogenic; Bhatt Circulation 2018)
axis: iatrogenic_tamponade_drainage_and_reversal
Selected axis "Iatrogenic tamponade — emergent drainage + anticoagulation reversal + surgical readiness (ESC 2015 §Iatrogenic; Bhatt Circulation 2018)" by default fallback (first axis)
  • normal saline
    first line
    isotonic_crystalloid
    500-1000 mL bolus • IV • rapid bolus then reassess
    triggers: hypotension_pre_drainage
    Bridge preload (ESC 2015)
    rxcui 9863
  • norepinephrine
    rescue
    vasopressor
    0.05-0.1 µg/kg/min titrate to MAP ≥65 • IV • continuous
    triggers: SBP_lt_85_despite_fluids
    Bridge only — does not address obstruction (Roy JAMA 2007)
    rxcui 7512
  • protamine
    first line
    heparin_antagonist
    1 mg per 100 U UFH (max 50 mg single dose) • IV • slow IV over 10 min
    triggers: active_ufh_at_time_of_perforation
    Reverse UFH; ESC 2015; standard cath lab tamponade reversal
    rxcui 8825
  • phytonadione
    first line
    vitamin_k
    10 mg IV slow over 10 min • IV • single dose
    triggers: active_warfarin_with_inr_supratherapeutic
    Vit K reverses warfarin synthesis defect; works over 6-12h (Bhatt Circulation 2018)
    rxcui 8308
  • 4-factor prothrombin complex concentrate
    first line
    pcc_4_factor
    25-50 U/kg based on INR • IV • single dose
    triggers: active_warfarin_with_life_threatening_bleeding
    Immediate factor replacement for warfarin reversal in major bleeding (Bhatt Circulation 2018)
    rxcui 1670383
  • idarucizumab
    first line
    monoclonal_antibody_dabigatran_reversal
    5 g IV (2 × 2.5 g vials) • IV • single dose
    triggers: active_dabigatran_with_life_threatening_bleeding
    RE-VERSE AD (Pollack NEJM 2017 PMID 28793172) — complete reversal within minutes
    rxcui 1716191
  • andexanet alfa
    first line
    modified_factor_xa_decoy
    low dose 400 mg bolus + 4 mg/min × 2h OR high dose 800 mg bolus + 8 mg/min × 2h based on FXa-DOAC dose + timing • IV • bolus + infusion
    triggers: active_apixaban_or_rivaroxaban_with_life_threatening_bleeding
    ANNEXA-4 (Connolly NEJM 2019 PMID 30730782) — rapid anti-FXa reversal
    rxcui 2045114
  • tranexamic acid
    add on
    antifibrinolytic
    1 g IV over 10 min then 1 g over 8h • IV • bolus + infusion
    triggers: traumatic_hemopericardium_or_persistent_bleeding
    CRASH-2 PMID 20554319 trauma application; consider in traumatic hemopericardium per damage-control resuscitation principles
    rxcui 10691

outpatient playbook — drug actions (3)

  1. 1. anticoagulation per indication
    rxcui 11289
    warfarin or DOAC at maintenance dose • PO • per agent
    trigger: Ongoing indication
    Bhatt Circulation 2018
  2. 2. completed colchicine course (1 mo) if post-pericardiotomy prophylaxis
    rxcui 2555
    completed; no continuation • PO • completed
    trigger: Post-cardiac-surgery prevention completed
    COPPS-2 PMID 25268438
  3. 3. colchicine + NSAID if post-pericardiotomy syndrome develops
    rxcui 2555
    0.5 mg BID + ibuprofen 600 mg TID × 1-3 mo • PO • BID + TID
    trigger: Symptomatic post-pericardiotomy syndrome
    Imazio CIRCS NEJM 2015 PMID 26315582

Auto-drafted A&P note

outpatient

Subjective

- Possible entry pathways: Acute hemodynamic decompensation in cath lab or EP lab during/post procedure → coronary perforation or LA/RA wall perforation (Holmes JACC 2011; Cappato CARE 2013); New chest pain + dyspnea + RBBB pattern hours-to-days post pacer/ICD implant → lead perforation (Cano AJC 2010); Post-cardiac-surgery hemodynamic decompensation in first 7d → post-cardiotomy tamponade or post-pericardiotomy syndrome (Imazio CIRCS NEJM 2015 PMID 26315582).

Objective

- No vitals, labs, or imaging entered for this encounter.

Assessment

**Cardiac tamponade — post-procedural / hemopericardium / iatrogenic** (cardio.cardiac-tamponade.post-procedural.v1).
Phenotype framing: Hemorrhagic exudate expected; rule in iatrogenic source (perforation site, lead malposition, anastomotic bleed, traumatic laceration) (Holmes JACC 2011; Cano AJC 2010; Cappato CARE 2013)
Scope: Post-procedural / iatrogenic tamponade — emergent pericardiocentesis + simultaneous cardiothoracic surgery activation + anticoagulation reversal (ESC 2015 §Iatrogenic Tamponade)

No severity triggers fired against current inputs.

Plan

Regimen axis: **Iatrogenic tamponade — emergent drainage + anticoagulation reversal + surgical readiness (ESC 2015 §Iatrogenic; Bhatt Circulation 2018)**.
1. normal saline 500-1000 mL bolus IV rapid bolus then reassess (isotonic_crystalloid, first line) — Bridge preload (ESC 2015)
2. norepinephrine 0.05-0.1 µg/kg/min titrate to MAP ≥65 IV continuous (vasopressor, rescue) — Bridge only — does not address obstruction (Roy JAMA 2007)
3. protamine 1 mg per 100 U UFH (max 50 mg single dose) IV slow IV over 10 min (heparin_antagonist, first line) — Reverse UFH; ESC 2015; standard cath lab tamponade reversal
4. phytonadione 10 mg IV slow over 10 min IV single dose (vitamin_k, first line) — Vit K reverses warfarin synthesis defect; works over 6-12h (Bhatt Circulation 2018)
5. 4-factor prothrombin complex concentrate 25-50 U/kg based on INR IV single dose (pcc_4_factor, first line) — Immediate factor replacement for warfarin reversal in major bleeding (Bhatt Circulation 2018)
6. idarucizumab 5 g IV (2 × 2.5 g vials) IV single dose (monoclonal_antibody_dabigatran_reversal, first line) — RE-VERSE AD (Pollack NEJM 2017 PMID 28793172) — complete reversal within minutes
7. andexanet alfa low dose 400 mg bolus + 4 mg/min × 2h OR high dose 800 mg bolus + 8 mg/min × 2h based on FXa-DOAC dose + timing IV bolus + infusion (modified_factor_xa_decoy, first line) — ANNEXA-4 (Connolly NEJM 2019 PMID 30730782) — rapid anti-FXa reversal
8. tranexamic acid 1 g IV over 10 min then 1 g over 8h IV bolus + infusion (antifibrinolytic, add on) — CRASH-2 PMID 20554319 trauma application; consider in traumatic hemopericardium per damage-control resuscitation principles

Setting playbook (outpatient) — Long-term surveillance for late complications (post-pericardiotomy syndrome, constrictive pericarditis); anticoagulation management; cardiology follow-up (ESC 2015; Imazio CIRCS PMID 26315582)
9. anticoagulation per indication warfarin or DOAC at maintenance dose PO per agent — Ongoing indication (Bhatt Circulation 2018)
10. completed colchicine course (1 mo) if post-pericardiotomy prophylaxis completed; no continuation PO completed — Post-cardiac-surgery prevention completed (COPPS-2 PMID 25268438)
11. colchicine + NSAID if post-pericardiotomy syndrome develops 0.5 mg BID + ibuprofen 600 mg TID × 1-3 mo PO BID + TID — Symptomatic post-pericardiotomy syndrome (Imazio CIRCS NEJM 2015 PMID 26315582)

Non-pharmacologic actions:
- Cardiology follow-up q3 mo for first year then annually
- Cardiac surgery follow-up per surgeon preference
- EP follow-up per device protocol
- Cardiac rehab if appropriate

AVOID / contraindication checks:
- Positive_pressure_ventilation_AVOID_pre_drain (ESC 2015)
- Type_a_dissection_LIMITED_drainage_full_drainage_precipitates_exsanguination (ESC 2015 §Aortic Dissection)
- Protamine_AVOID_severe_anaphylaxis_history_or_diabetic_on_nph_insulin_relative (drug label)
- Andexanet_caution_with_prothrombotic_risk_thromboembolism_signal_in_annexa_4 (Connolly NEJM 2019)
- Idarucizumab_appropriate_only_for_dabigatran_no_effect_on_xa_drugs (Pollack NEJM 2017)
- Colchicine_AVOID_immediate_post_op_wound_healing_concern (Imazio CIRCS NEJM 2015 PMID 26315582)

Monitoring

Regimen monitoring:
- continuous ECG during drainage (ESC 2015)
- art line BP pre and post (Adler 2015)
- echo post drain immediate then q4-6h x 24h then q12-24h x 48h (rapid re-accumulation possible if persistent bleeding)
- serial hemoglobin q2h x 12h then q6h (track ongoing bleeding)
- coagulation correction tracking inr ptt post reversal (Bhatt 2018)
- fluid analysis hematocrit compare to serum for active bleeding (ESC 2015)
- surgical site monitoring if window or exploration performed

Setting (outpatient) monitoring:
- Echo at 1, 3, 6 mo then annually
- CBC + CRP if symptoms suggest recurrence
- INR per anticoagulation

Monitoring phase: Re-accumulation surveillance (echo q4-6h × 24h then q12-24h × 48h); serial Hb; coagulation correction tracking; surgical wound monitoring if exploration performed (ESC 2015 §Follow-up)

Disposition

Current setting: outpatient — Long-term surveillance for late complications (post-pericardiotomy syndrome, constrictive pericarditis); anticoagulation management; cardiology follow-up (ESC 2015; Imazio CIRCS PMID 26315582)

Disposition criteria:
- No recurrence + stable hardware + completed prophylaxis + anticoagulation stable → routine annual cardiology follow-up

Escalation triggers (move to higher acuity):
- Late post-pericardiotomy syndrome → colchicine + NSAID per Imazio CIRCS
- Constrictive pericarditis pattern (persistent dyspnea + RH cath shows constrictive physiology) → CMR + cardiothoracic for pericardiectomy evaluation
- Recurrent tamponade → re-route to acute pathway
- Hardware-related complications (lead displacement, valve dysfunction, graft occlusion) → device-specific intervention

Earlier-Return Triggers

Return-precaution thresholds (watch for):
- [LIFE_THREATENING] Persistent pericardial bleeding (>200 mL/h drainage output OR ongoing transfusion requirement) despite reversal + drainage — surgical exploration mandatory (ESC 2015 §Iatrogenic; Holmes JACC 2011)
- [LIFE_THREATENING] Active warfarin/DOAC/UFH at time of perforation with hemodynamic compromise — emergent reversal mandatory (Bhatt Circulation 2018; Pollack NEJM 2017; Connolly NEJM 2019)
- [LIFE_THREATENING] Tamponade in first 7d post-cardiac-surgery with loculated clot on echo — needle pericardiocentesis often inadequate (ESC 2015 §Post-Cardiotomy)

Citations

- 2015 ESC Guidelines for the diagnosis and management of pericardial diseases (Adler EHJ 2015 PMID 26320112) §Iatrogenic Tamponade — remains current as of 2026-05-14. Holmes JACC 2011 (post-PCI), Cano AJC 2010 (lead perforation), Cappato Circ Arrhythm Electrophysiol 2013 (post-AF ablation), Imazio CIRCS NEJM 2015 PMID 26315582 (post-pericardiotomy), and Bhatt Circulation 2018 + Pollack NEJM 2017 (RE-VERSE AD) + Connolly NEJM 2019 (ANNEXA-4) anchor iatrogenic-specific reversal + surgical activation pathways. [PMID:26320112](https://pubmed.ncbi.nlm.nih.gov/26320112/)
- Cited evidence (PMID 17456823) [PMID:17456823](https://pubmed.ncbi.nlm.nih.gov/17456823/)
- Cited evidence (PMID 20656240) [PMID:20656240](https://pubmed.ncbi.nlm.nih.gov/20656240/)
- Cited evidence (PMID 12122206) [PMID:12122206](https://pubmed.ncbi.nlm.nih.gov/12122206/)
- Cited evidence (PMID 26315582) [PMID:26315582](https://pubmed.ncbi.nlm.nih.gov/26315582/)

Last reconciled with current guidelines: 2026-05-14.
References
  • 2015 ESC Guidelines for the diagnosis and management of pericardial diseases (Adler EHJ 2015 PMID 26320112) §Iatrogenic Tamponade — remains current as of 2026-05-14. Holmes JACC 2011 (post-PCI), Cano AJC 2010 (lead perforation), Cappato Circ Arrhythm Electrophysiol 2013 (post-AF ablation), Imazio CIRCS NEJM 2015 PMID 26315582 (post-pericardiotomy), and Bhatt Circulation 2018 + Pollack NEJM 2017 (RE-VERSE AD) + Connolly NEJM 2019 (ANNEXA-4) anchor iatrogenic-specific reversal + surgical activation pathways. — PMID:26320112
  • Cited evidence (PMID 17456823) — PMID:17456823
  • Cited evidence (PMID 20656240) — PMID:20656240
  • Cited evidence (PMID 12122206) — PMID:12122206
  • Cited evidence (PMID 26315582) — PMID:26315582